Related Experiment Video
Updated: Jun 11, 2026
13:21
Preparation, Purification, and Characterization of Lanthanide Complexes for Use as Contrast Agents for Magnetic Resonance Imaging
Published on: July 21, 2011
Biocompatible Nanocomplexes for Molecular Targeted MRI Contrast Agent.
Nanoscale Research Letters
|July 3, 2010
Summary
Researchers developed poly lactic acid-polyethylene glycol/gadolinium-diethylenetriamine-pentaacetic acid (PLA-PEG/Gd-DTPA) nanocomplexes for enhanced liver imaging. These biocompatible agents show improved contrast and stability for early Hepatocellular carcinoma diagnosis.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Medical Imaging
Background:
- Early diagnosis of Hepatocellular carcinoma (HCC) is crucial for effective treatment.
- Conventional MRI contrast agents have limitations in stability and targeting.
- Development of novel biocompatible contrast agents is essential for improved HCC detection.
Purpose of the Study:
- To synthesize and characterize poly lactic acid-polyethylene glycol/gadolinium-diethylenetriamine-pentaacetic acid (PLA-PEG/Gd-DTPA) nanocomplexes.
- To evaluate the potential of these nanocomplexes as molecular MRI contrast agents for HCC.
- To assess the stability, imaging performance, and biodistribution of the nanocomplexes.
Main Methods:
- PLA-PEG nanoparticles and Gd-DTPA were combined using self-assembly nanotechnology.
- Physicochemical properties were analyzed using atomic force microscopy and photon correlation spectroscopy.
- MRI performance was evaluated on a 3.0 T clinical imager, with stability and in vivo studies in rats.
Main Results:
- PLA-PEG/Gd-DTPA nanocomplexes exhibited a mean size of 187.9 nm with good stability.
- MRI tests showed a direct correlation between nanocomplex concentration and imaging intensity (r=0.987).
- In vivo studies demonstrated superior contrast enhancement and longer stagnation time in rat livers compared to commercial Gd-DTPA.
Conclusions:
- PLA-PEG/Gd-DTPA nanocomplexes are easily prepared, biocompatible, and possess high plasma stability.
- These nanocomplexes offer enhanced liver targeting and improved MRI contrast effects.
- They represent a promising candidate for molecular targeted imaging in early Hepatocellular carcinoma diagnosis.
Related Concept Videos
01:24Magnetic Resonance Imaging
Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...
01:14Imaging Studies I: CT and MRI
Introduction: MRI and CT scans are crucial advancements in medical imaging techniques, playing a vital role in diagnosing conditions related to the gastrointestinal (GI) system. Each scan serves distinct purposes, targets specific areas, and requires unique nursing duties.
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...